Signaling Pathway
ANX005 is a recombinant antibody specifically targeting C1q, the initiating molecule of the classical complement cascade. By inhibiting C1q, ANX005 is instrumental in the study of its role in autoimmune and neurodegenerative diseases. This antibody serves as a crucial tool for researchers investigating the mechanisms of immune response and disease progression in these conditions.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | ANX005 is a recombinant antibody specifically targeting C1q, the initiating molecule of the classical complement cascade. By inhibiting C1q, ANX005 is instrumental in the study of its role in autoimmune and neurodegenerative diseases. This antibody serves as a crucial tool for researchers investigating the mechanisms of immune response and disease progression in these conditions. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
